Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valder R Arruda

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Blood|June 26, 2004
Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX geneDenise E Sabatino, Elina Armstrong, Shyrie Edmonson, et al.
Blood|January 9, 2015
AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and miceJulie M Crudele, Jonathan D Finn, Joshua I Siner, et al.
Blood|September 13, 2003
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Valder R Arruda, Joerg Schuettrumpf, Roland W Herzog, et al.
Blood|September 23, 2009
Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A modelDenise E Sabatino, Christian Furlan Freguia, Raffaella Toso, et al.
Plos One|October 3, 2013
Characterization of naturally-occurring humoral immunity to AAV in sheepJoseph Tellez, Kim Van Vliet, Yu-Shan Tseng, et al.
The Journal of Clinical Investigation|March 2, 2021
B cell-activating factor modulates the factor VIII immune response in hemophilia ABhavya S Doshi, Jyoti Rana, Giancarlo Castaman, et al.
ILAR Journal|March 19, 2009
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiencyTimothy C Nichols, Aaron M Dillow, Helen W G Franck, et al.
Thrombosis and Haemostasis|July 23, 2004
Platelet glycoprotein Ibalpha polymorphisms modulate the risk for myocardial infarctionMargareth C Ozelo, Andrea F Origa, Francisco J P Aranha, et al.
Thrombosis Research|September 7, 2018
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXaWilliam E Plautz, Rima Chattopadhyay, Ester I Goldfeld, et al.
Blood|October 30, 2008
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapyGlenn P Niemeyer, Roland W Herzog, Jane Mount, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Blood|June 26, 2004
Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX geneDenise E Sabatino, Elina Armstrong, Shyrie Edmonson, et al.
Blood|January 9, 2015
AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and miceJulie M Crudele, Jonathan D Finn, Joshua I Siner, et al.
Blood|September 13, 2003
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Valder R Arruda, Joerg Schuettrumpf, Roland W Herzog, et al.
Blood|September 23, 2009
Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A modelDenise E Sabatino, Christian Furlan Freguia, Raffaella Toso, et al.
Plos One|October 3, 2013
Characterization of naturally-occurring humoral immunity to AAV in sheepJoseph Tellez, Kim Van Vliet, Yu-Shan Tseng, et al.
The Journal of Clinical Investigation|March 2, 2021
B cell-activating factor modulates the factor VIII immune response in hemophilia ABhavya S Doshi, Jyoti Rana, Giancarlo Castaman, et al.
ILAR Journal|March 19, 2009
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiencyTimothy C Nichols, Aaron M Dillow, Helen W G Franck, et al.
Thrombosis and Haemostasis|July 23, 2004
Platelet glycoprotein Ibalpha polymorphisms modulate the risk for myocardial infarctionMargareth C Ozelo, Andrea F Origa, Francisco J P Aranha, et al.
Thrombosis Research|September 7, 2018
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXaWilliam E Plautz, Rima Chattopadhyay, Ester I Goldfeld, et al.
Blood|October 30, 2008
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapyGlenn P Niemeyer, Roland W Herzog, Jane Mount, et al.
Pageof 9